Dr. Bruno Oesch

Chief Executive Officer

  • Bruno Oesch is co-founder of Malcisbo AG.

    He was also a founder of Neurotune AG as a spin-off from Prionics AG in 2005. Since the start of the company he serves as the Chairman of the Board of Directors. From 2009-2011 he also acted as CEO.

    Previously, Bruno also co-founded Prionics AG as a spin-off from the University of Zurich in early 1997 and acted as Co-CEO, Head of R & D and Chairman of the Board of Prionics.

    He graduated from the ETH Zurich with a Master's degree in Natural Sciences. For his PhD in prion diseases, he joined Prof. Charles Weissmann at the University of Zurich. Later, he worked at the University of California in San Francisco in Prof. Stanley Prusiner's Lab. Subsequently he established his own research group at the Brain Research Institute of the University of Zurich, out of which Prionics was started. Bruno is honorary doctor (Dr.h.c.) at the University of Zurich.

Back to overview

Latest News

  • 21 January 2019

    Malcisbo has been selected as emerging company to present at the Animal Health Investment Forum in London (Feb 2019)

  • 26 November 2018

    VetBioNet grant

    Malcisbo wins a grant to perform an APP challenge trial in a BLS3 facility.

  • 25 January 2017

    Malcisbo has been selected as emerging company to present at the Animal Health Investment Forum in London (Feb 2017)